Sublicense Fees. Licensee will pay Sublicense Fees in an amount equal to twenty five percent (25%) of Non-Royalty Sublicensing Consideration on or before the Quarterly Payment Deadline for the Contract Quarter during which Licensee receives such consideration.
Appears in 3 contracts
Samples: Patent & Technology License Agreement (ADiTx Therapeutics, Inc.), Patent & Technology License Agreement, Patent & Technology License Agreement (ADiTx Therapeutics, Inc.)
Sublicense Fees. Licensee will pay Sublicense Fees in an amount equal to twenty five percent (25%) ___% of Non-Royalty Sublicensing Consideration on or before the Quarterly Payment Deadline for the Contract Quarter during which Licensee receives such consideration.
Appears in 3 contracts
Samples: Patent & Technology License Agreement, Patent & Technology License Agreement, Patent & Technology License Agreement
Sublicense Fees. Licensee will pay Sublicense Fees in an amount equal to twenty five percent (25%) ___% of Non-Royalty Sublicensing Consideration on or before the Quarterly Payment Deadline for the Contract Quarter during which Licensee receives such considerationQuarter.
Appears in 2 contracts
Samples: Patent & Technology License Agreement, Patent License Agreement
Sublicense Fees. Licensee will pay Sublicense Fees in an amount equal to twenty five percent (25%) [**]% of Non-Royalty Sublicensing Consideration on or before the Quarterly Payment Deadline for the Contract Quarter during which Licensee receives such considerationQuarter; provided that no Sublicense Fees shall be due for transactions that occur prior to the Sale of Licensee.
Appears in 1 contract
Samples: Patent & Technology License Agreement (Aileron Therapeutics Inc)